...Yoshikazu Toshima; Keiki Yokoo; Koki Kamata; Takayuki Nagao; Satoshi Ota; Gen Yamada; Hirofumi Chiba Introduction: Immune-checkpoint inhibitors, such as pembrolizumab, have been used for non-small cell lung cancer treatment but are often associated with immune-related adverse events (irAEs). Case...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 Immune-checkpoint inhibitors...